BioPalette Logo (WIPO, 01/09/2018)
WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark BioPalette was filed as Word mark on 01/09/2018 at the World Intellectual Property Organization.
| Trademark form | Word mark |
| File reference | 1426247 |
| Countries | 
|
| Base trademark |
No. 2017-093679,
July 12, 2017
|
| Application date | January 9, 2018 |
| Expiration date | January 9, 2028 |
Trademark owner
6-3-7 Minatojima-Minamimachi,
Chuo-ku, Kobe-shi
JP
Chuo-ku, Kobe-shi
JP
Trademark representatives
c/o Ishikawa Patent & Trademark Firm,
Livio RAISON SHINAGAWA TOGOSHI 403,
JP
goods and services
01
Chemicals; chemical reagents for use in genetic research;
chemical reagents for use in genetic research in the field
of genome or gene editing; chemicals produced by genome or
gene editing operation; chemical reagent for separation or
production of gene editing substances; genes of seeds for
agricultural production produced by genome or gene editing
operation; cultures of microorganisms produced by genome or
gene editing operation, other than for medical or veterinary
use; diagnostic reagents for scientific or research use in
the field of genome or gene editing; genes of seeds for
agricultural production; cultures of microorganisms, other
than for medical or veterinary use
05
Pharmaceutical preparations; living cells, microorganisms,
proteins, peptides, nucleic acid sequences, or combination
thereof for medical or veterinary purposes; pharmaceutical
preparations produced by modifying genes; pharmaceutical
preparations produced by genome or gene editing operation;
reagents for medical or pharmaceutical research purposes
produced by genome or gene editing operation; reagents for
medical or pharmaceutical research purposes in the field of
genome or gene editing operation; chemical reagents for
medical purposes produced by genome or gene editing
operation; chemical reagents for medical purposes in the
field of genome or gene editing operation; cultures of
microorganisms for medical or veterinary use produced by
genome or gene editing operation; living cells,
microorganisms, proteins, peptides, nucleic acid sequences,
or combination thereof for medical or veterinary purposes
produced by genome or gene editing operation; biological
tissue for surgical implantation produced by genome or gene
editing operation; pharmaceutical and biological
preparations, or diagnostic products based on gene, genome
and cellular editing, modulation, modification, engineering,
regulation, repair and therapy; cultures of microorganisms
for medical or veterinary purposes; biological tissue
cultures for medical or veterinary purposes
31
Seeds; seeds produced by genome or gene editing operation;
seeds in which herbicide tolerance genes are incorporated by
genome or gene editing operation; seeds for vegetables
produced by genome or gene editing operation; seeds for
agricultural purposes; seeds for vegetables; seeds for
planting; genetically modified seeds including seeds for
agricultural purposes, flowers, planting, or vegetable
42
Research and development in the field of bacteriology,
cytology, antibody technology, chemistry, immunology, or
gene expression systems; scientific research in the field of
genetics or genetic engineering; DNA screening for
scientific research purposes; research and development,
quality control, or advisory services relating thereto in
the field of proteins, antibodies, microorganisms, or cells;
structural and functional analysis of the genome with genome
editing technology; DNA screening for scientific research
purposes with genome editing technology; research,
development, advisory services, or information services
relating to genome editing technology; research and
development, quality control, or advisory services relating
thereto in the field of proteins, antibodies,
microorganisms, or cells with genome editing technology;
research and development in the field of bacteriology,
cytology, antibody technology, chemistry, immunology, or
gene expression systems with genome editing technology;
scientific research in the field of genetics or genetic
engineering with genome editing technology; testing,
inspection or research of pharmaceuticals, cosmetics or
foodstuffs with genome editing technology; development of
pharmaceuticals, cosmetics or foodstuffs with genome editing
technology; advisory services relating to development of
pharmaceuticals, cosmetics or foodstuffs with genome editing
technology; information services relating to development of
pharmaceuticals, cosmetics or foodstuffs with genome editing
technology; testing, inspection or research relating to
medical treatment or medical technology with genome editing
technology; information services for testing, inspection or
research relating to medical treatment or medical technology
with genome editing technology; testing or research relating
to genome or gene to which genome editing technology is
applied; scientific and medical research and survey, or
scientific or technical research and development of
bioinformatic tools in the fields of editing, modulation,
modification, engineering, regulation, repair and therapy of
gene, genome and cells to develop human pharmaceutical,
biological preparations, or diagnostic products and
services; research and development for the pharmaceutical
industry and biotechnology industry with genome editing
technology; research and development of biotechnology for
others; research and development of genome editing
technology for others; development of pharmaceutical
preparations and medicines; biotechnology research; research
and development in the field of genome or biotechnology;
advisory services in the field of genome or biotechnology;
structural and functional analysis of genomes; scientific
and medical research in the fields of gene, genome and
cellular editing, modulation, modification, engineering,
regulation, repair and therapy to develop human
pharmaceutical and biological preparations to be delivered
or applied ex vivo to human cells for use in human
therapeutics and diagnostic products and services;
scientific study and research in the fields of gene, genome
and cellular editing, modulation, modification, engineering,
regulation, repair and therapy to develop human
pharmaceutical and biological preparations to be delivered
or applied ex vivo to human cells for use in human
therapeutics and diagnostic products and services; design of
bioinformatic algorithms and models for use in scientific
and medical research in the fields of gene, genome and
cellular editing, modulation, modification, engineering,
regulation, repair and therapy to develop human
pharmaceutical and biological preparations to be delivered
or applied ex vivo to human cells for use in human
therapeutics and diagnostic products and services;
laboratory research in the field of pharmaceuticals;
conducting clinical trials for pharmaceuticals; laboratory
research in the field of gene expression; research and
development services in the field of gene expression
systems; research and development services in the field of
microorganisms and cells; genetic engineering services
relating to plants
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| January 5, 2021 | 2021/2 Gaz | EM | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| September 28, 2019 | 2019/40 Gaz | US | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| March 22, 2019 | 2019/15 Gaz | CN | Rejection |
| February 22, 2019 | 2019/10 Gaz | EM | Rejection |
| November 7, 2018 | 2018/45 Gaz | US | Rejection |
| January 9, 2018 | 2018/38 Gaz | JP | Registration |
ID: 141426247